Favorece la relajación, mejora el sueño y la claridad mental.

• Reishi (Ganoderma lucidum) extracto seco titulado al 25% en polisacáridos
• Complejo vegetal de vitaminas del grupo B de trigo sarraceno
• Hipérico herba extracto seco (tit. 0,3% hipericina)
• Passiflora flores extracto seco (tit. 3,5% flavonoides)
• Centella hojas extracto seco (tit. 40% triterpenos)
• Cápsula de celulosa vegetal

2-4 cápsulas al día

Envase de 60 cápsulas

• Incluido en el registro de complementos alimenticios: código 71757
• Código Paraf: A925603779
• Código EAN: 8059173430062

1. Mizuno, T. (1996). Oriental Medicinal tradition of “Ganoderma lucidum (Reishi)” in China. In T. Mizuno & B.-K. Kim(Eds.), Ganoderma lucidum (pp. 101-106). Seoul, Korea : IlYang Pharm. Co. Ltd
2. Kim KC, Kim IG. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation.Int J Mol Med 1999 Sep;4(3):273-7
3. Wachtel-Galor S, Szeto YT, Tomlinson B, et al. Ganoderma lucidum (‘Lingzhi’); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. Feb 2004;55(1):75-83
4. T.A. Ajith, N.P. Sudheesh, D. Roshny, G. Abishek and K.K. Janardhanan. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats Experimental Gerontology Volume 44, Issue 3, March 2009, Pages 219-223
5. Tang W, Gao Y, Chen G, et al. A Randomized, Double-Blind and Placebo-Controlled Study of a Ganoderma lucidum Polysaccharide Extract in Neurasthenia. J Med Food. 2005;8:53-58
6. CS Lai, MS Yu, WH Yuen, KF So, SY Zee, and RC Chang. Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res, Jan 2008; 1190: 215-24
7. R Zhang, S Xu, Y Cai, M Zhou, X Zuo and P Chan. Ganoderma lucidum Protects Dopaminergic Neuron Degeneration Through Inhibition of Microglial Activation. eCAM Advance Access published July 16, 2009
8. ZY Zhou, YP Tang, J Xiang, P Wua, HM Jin, Z Wang, M Mori, and DF Cai. Neuroprotective effects of water-soluble Ganoderma lucidum polysaccharides on cerebral ischemic injury in rats. J Ethnopharmacol, August 19, 2010; 131(1): 154-64
9. Zhou Y, Qu ZQ, Zeng YS, Lin YK, Li Y, Chung P, Wong R, Hagg U. Neuroprotective effect of preadministration with Ganoderma lucidum spore on rat hippocampus. Exp Toxicol Pathol, November 1, 2012; 64(7-8): 673-80
10. Ajith TA et al. Effect of Ganoderma lucidum on the activities of mitochondrial dehydrogenases and complex I and II of electron transport chain in the brain of aged rats. ExpGerontol 2009; 44(3):219-223
11. Ding H, et al. Ganoderma lucidum extract protects dopaminergic neurons through inhibiting the production of inflammatory mediators by activated microglia. Sheng Li Xue Bao. 2010 Dec 25;62(6):547-54
12. Zhao HB, et al. Polysaccharide extract isolated from ganoderma lucidum protects rat cerebral cortical neurons from hypoxia/reoxygenation injury. J Pharmacol Sci. 2004 Jun;95(2):294-8
13. Zhang R, et al. Ganoderma lucidum protects dopaminergic neuron degeneration through inhibition of microglial activation. Evid Based Complement Alternat Med. 2011;2011:156810
14. Chen LW, Horng LY, Wu CL, Sung HC, Wu RT. Activating mitochondrial regulator PGC-1alpha expression by astrocytic NGF is a therapeutic strategy for Huntington’s disease. Neuropharmacology. 2012 May 24
15. XY Cui, SY Cui, J Zhang, ZJ Wang, B Yu, ZF Sheng, XQ Zhang, and YH Zhang Extract of Ganoderma lucidum prolongs sleep time in rats. J Ethnopharmacol, February 15, 2012; 139(3): 796-800
16. Lee JM et al. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytotherapy Res; 15: 245-249
17. Campanini E. – “ Dizionario di fitoterapia e piante medicinali”– Milano, 2012
18. Fassina G. – “Lezioni di farmacologia”- Cedam, Padova, 1995
19. Speroni E. et al. Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med. 54, 488-491, 1988
20. Bourin A.V. et al. A combination of plant extracts in the treatment of outpatients with adjustement disorders with anxious mood. Controlled study versus placebo. Fundam. Clin. Pharmacol. 11, 127-132, 1997
21. Speroni E. et al. Role of chrisin in the sedative effects of Passiflora incarnata L. Phytother. Res. 10, suppl. 1, S 98- S 100, 1996
22. Speroni E. et al. Sedative effects of crude extracts of Passiflora incarnata after oral administration. Phytother. Res. 10, suppl. 1, S 92-S 94, 1996
23. Dhawan K. et al. Anxiolytic activity of aerial and underground parts of Passiflora incarnata. Fitoterapia 72, 922-926, 2001
24. Dhawan K. et al. Anti-anxiety studies on extracts of Passiflora incarnata Linneaus. J. Ethnopharmacol. 78, 165-170, 2001
25. Akhondzadek S. et al. Passionflower in the treatment of generalized anxiety: a pilot double blind randomized controlled trial with oxazepam. J. Clin. Pharm. Ther. 26, 363-377, 2001
26. Dhawan K. et al. Comparative Anxiolytic Activity Profile of Various Preparations of Passiflora incarnata Linneaus: A Comment on Medicinal Plants’ Standardization. J Altern Complement Med 8(3):283-91, 2002
27. A Szegedi, R Kohnen, A Dienel, M Kieser. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John’s wort): randomised controlled double blind non-inferiority trial versus paroxetine. BMJ 2005;330:503
28. Monograph. Hypericum perforatum. Altern Med Rev. 2004 Sep; 9 (3):318-25
29. Linde K, Mulrow CD, Berner M, Egger M. St John’s worth for depression. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD000448
30. James, J.T.; Dubery, I.A. Pentacyclic Triterpenoids from the Medicinal Herb, Centella asiatica (L.) Urban. Molecules 2009, 14, 3922-3941
31. Blumenthal M et al. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Klein S, Rister RS, translators. Austin (TX): American Botanical Council; Boston (MA): Integrative Medicine Communications; 1998